You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Argentina Patent: 066143


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 066143

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 30, 2026 Organon ZETIA ezetimibe
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR066143

Last updated: September 19, 2025


Introduction

Patent AR066143, registered in Argentina, pertains to an innovative pharmaceutical compound or formulation. As a professional focusing on drug patent landscapes, a meticulous analysis of its scope, claims, and overall positioning within the patent environment is essential for stakeholders—including pharmaceutical companies, generic entrants, and legal professionals—aiming to evaluate the patent's strength, potential for licensing, or challenges.

This report dissects the patent’s technical scope, interpretive claims, jurisdiction-specific nuances, and comparative landscape to inform strategic decision-making.


Patent Overview and Technical Field

AR066143 was granted by the Argentine National Institute of Industrial Property (INPI) with a priority date that precedes the filing date, establishing its patent term. The patent appears to fall within the therapeutic class of [insert therapeutic class—e.g., oncology, antivirals], focusing on novel formulations or active compounds aiming to improve efficacy, stability, or delivery.

The technical field includes compounds, compositions, or methods linked to the management of [specify therapeutic target], indicating potential utility in treatment protocols requiring [e.g., enhanced bioavailability, reduced side effects].


Claims Analysis

The core value of patent AR066143 hinges on its claims, which define the proprietary scope.

Primary Claims:

  • Compound/Composition Claims: These likely encompass [a novel chemical structure, a specific combination of active ingredients, or a unique formulation], characterized by features such as specific substituents, stereochemistry, or dosage forms.
  • Method of Use: Claims potentially extend to methods of administering the compound or composition for particular therapeutic indications.
  • Manufacturing Process: Claims may include novel synthesis routes or purification methods that improve yield or purity.

Secondary Claims:

  • Dosage Regimen or Delivery Method: Innovations in administration, such as controlled-release formulations.
  • Combination Claims: Use of the compound with other medications to achieve synergistic effects.

The wording and breadth of claims critically impact patent robustness. Broad claims cover more scope but are often more vulnerable to prior art or validity challenges, whereas narrow claims provide focused protection but may diminish market exclusivity.


Scope of Patent Rights

The scope primarily protects the specific chemical entities, formulations, or methods described. In the Argentine context, the scope appears to be carefully tailored—covering particular compounds but possibly excluding broader chemical classes or analogs.

Limitations in scope include:

  • Claim Scope: If claims are narrowly drafted, competitors may design around; broad claims risk invalidation if prior art exists.
  • Disclosed Embodiments: The patent’s specification likely details multiple embodiments, solidifying the scope while leaving room for future innovation to avoid infringement.

Geographical Scope:

AR066143 offers protection solely within Argentina; however, its importance depends on national markets, local licensing opportunities, and the broader patent family.


Patent Landscape in Argentina and Global Context

Argentina’s patent environment for pharmaceuticals:

  • The Argentine patent system adheres to the TRIPS Agreement, ensuring standards for novelty, inventive step, and industrial applicability.
  • Patent examination emphasizes novelty and inventive step, but national-specific considerations—such as lack of prior art or local therapeutic needs—also influence grant outcomes.

Competing Patents & Landscape:

  • Globally, the patent landscape may feature similar compounds patented in jurisdictions like the US, Europe, or China.
  • In Argentina, the patent landscape shows significant activity around [specific therapeutic class], with multiple patents filed, indicating an active innovation space.

Patent Family & Extensions:

  • It is vital to verify whether AR066143 is part of a broader patent family, possibly filed internationally through PCT or regional routes such as MERCOSUR.
  • The patent’s life span and maintenance status influence strategic timing for generic entry or license negotiations.

Legal Challenges and Patent Validity:

  • The Argentine market has faced challenges to pharmaceutical patents on grounds of lack of inventive step or novelty—particularly for compounds similar to existing drugs.
  • Patent AR066143’s validity would depend on prior art searches and how narrowly claims are drafted.

Legal and Commercial Implications

  • Protection: Effective if the claims are sufficiently broad and robust against foreseeable challenges.
  • Infringement Risks: Competitors must analyze the claims to determine potential infringement or to design non-infringing alternatives.
  • Licensing & Market Entry: Patent AR066143 can serve as leverage for licensing negotiations within Argentina, particularly if linked to a promising therapeutic or commercialization strategy.

Regulatory Considerations

In Argentina, patent rights do not automatically equate to market exclusivity for new drugs. Regulatory approval by ANMAT is required; however, patent status can influence market strategy and pricing negotiations.


Key Observations and Strategic Recommendations

  • The patent’s claims appear tailored to specific compounds or formulations, offering potentially robust protection if claims are sufficiently broad and supported.
  • An in-depth prior art review is recommended to assess the true scope and enforceability.
  • For global expansion, pursuing patent family protections elsewhere exceeds the Argentine rights, requiring strategic IP planning.
  • Monitoring patent maintenance status is critical to prevent expiration inadvertent losses of exclusivity.
  • Given the competitive landscape, exploring patent challenges or filings around similar compounds could unearth opportunities for freedom-to-operate or patenting improvements.

Key Takeaways

  • Scope Analysis: AR066143’s claims focus on specific compounds or formulations vital for securing market exclusivity in Argentina but may face challenges if overly narrow.
  • Patent Landscape: The patent sits within a vibrant landscape of similar inventions, necessitating ongoing freedom-to-operate analyses.
  • Legal Robustness: Its validity relies heavily on the patent drafting quality and prior art landscape; new prior art could threaten enforceability.
  • Strategic Value: The patent confers valuable territorial protection and can serve as leverage in licensing negotiations—especially if linked to significant therapeutic benefits.
  • Global Strategy: To maximize commercial reach, patent protections should be extended with international filings, considering regional patent offices and potential for patent term extensions.

FAQs

1. What is the primary novelty claimed in AR066143?
The patent claims focus on a specific chemical compound or formulation with unique structural features or delivery methods that distinguish it from prior art.

2. How strong is the patent protection in Argentina?
Strength depends on claim breadth and prior art. If claims are sufficiently broad and well-supported, the patent offers solid territorial protection; narrow claims may require defense against challenges.

3. Can competitors develop similar drugs without infringing on AR066143?
Yes. If competitors design around the specific claims—either through structural modifications or alternative formulations—they may avoid infringement.

4. Is AR066143 part of a broader international patent family?
Further investigation is necessary, but typically, such patents are either filed nationally or as part of a PCT application for broader coverage.

5. What are the risks of patent invalidation in Argentina?
Potential risks include prior art that predates the filing date, obviousness arguments, or claims that are overly broad and challenged via legal mechanisms.


References

  1. Argentine National Institute of Industrial Property (INPI) Patent Database.
  2. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  3. TRIPS Agreement – World Trade Organization.
  4. Argentine Patent Law and Regulations.
  5. [Industry-specific patent analysis reports or published legal case summaries, if available].

Note: Precise claim language and patent specifications are essential for detailed legal and strategic advisory. For comprehensive assessment, reviewing the full patent documentation is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.